Medical Journals

Comparison of the Reproductive Biology Between Acaricide-resistant and Acaricide-susceptible Rhipicephalus (Boophilus) Microplus (Acari: Ixodidae).

Authors:
  • Davey Ronald B
  • George John E
  • Miller Robert J

From: USDA, ARS, Cattle Fever Tick Research Lab., Moore Air Base, Bldg. 6419, 22675 N. Moorefield Rd., Edinburgh, TX 78541, USA. Ronald.Davy@ars.usda.gov

Veterinary parasitology

  • Publish Date: Jun 2006
  • ISSN: 0304-4017
  • Volume: 139
  • Issue: 1-3
  • Pages: 211-20
  • Medium: Print
  • Language: English
  • Citation (JAMA): Davey Ronald B, George John E, Miller Robert J, et al. Comparison of the Reproductive Biology Between Acaricide-resistant and Acaricide-susceptible Rhipicephalus (Boophilus) Microplus (Acari: Ixodidae).. Vet. Parasitol. Jun 2006;139:211-20

Abstract

The reproductive fitness of Rhipicephalus (Boophilus) microplus (Canestrini) strains resistant to organophosphate (OP), pyrethroid (P), or formamidine (F) acaricides was compared to an acaricide-susceptible (SUS) strain to determine whether the acquisition of resistance affected reproductive fitness in the resistant strains. The SUS strain females had a 3.0 days preoviposition period, a 12.1 days oviposition period, a 22.5 days egg incubation period, a mean of 3670 eggs per female, and a mean percentage egg hatch of 78.1%, which were all remarkably similar to these same parameters reported for this species throughout the world. The reproductive biology of the P-resistant strain (PYR) and the F-resistant strain (FOR) were, for the most part, similar to those of the SUS strain. In the few instances where statistical differences did occur there was little evidence that the variation had any biological basis that could be attributed to a reduction in fitness related to resistance to P or F acaricides. Although the comparison of reproductive parameters of the OP-resistant strain (OPR) and the SUS strain identified statistical differences between the mean egg incubation and oviposition periods, the magnitude of the differences was not sufficient to conclude that the OPR strain was biologically less fit than the SUS strain. However, the OPR strain produced 30% fewer eggs (2562 eggs per female) than the SUS strain (3670 eggs per female) indicating the acquisition of resistance placed the OPR at a selective disadvantage relative to the SUS strain. This coupled with a lower, though non-significant, egg hatch was used to predict there would be a reduction of at least 34.1% in larval numbers available to potentially re-infest subsequent cattle than were available from the SUS strain. These data may aid the development of management strategies that can be used to control OP-resistant ticks.

Mesh Headings (Keywords): Amidines, Animals, Female, Insecticide Resistance, Insecticides, Male, Oviposition, Phosphoric Acid Esters, Pyrethrins, Reproduction, Rhipicephalus, Time Factors


Check for Full Text / PubMed Unique Identifier (PMID): 16584844


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.